MYD88 and pancreatic neoplasm: Whereas TLR4−/− mice showed decreased tumour growth in a murine model of pancreatic cancer, inhibition of MyD88 accelerated tumour development [41] as well as an increased TLR4 expression correlated with tumour size, lymph node involvement, venous invasion and pathological stage [39].